MedPath

Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis. - ND

Conditions
Patients waiting for first corpse kidney transplantation or re-transplantation, with PRA values > 50%
MedDRA version: 9.1Level: LLTClassification code 10023439Term: Kidney transplant rejection
Registration Number
EUCTR2008-007047-13-IT
Lead Sponsor
OSPEDALE POLICLINICO S. MATTEO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients of 18-70 years old; Patients in emodialysis suitable for kidney transplantation; patients with PRA > 50%; absence of active infections and procalcitonine in the normality ranges; absence of neoplastic processes; absence of active heart diseases; signed informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Absence of one of the inclusion criteria.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath